Open Access

Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells

  • Authors:
    • Rubí Viedma-Rodriguez
    • Luis Arturo Baiza-Gutman
    • Alejandro García-Carrancá
    • Leticia Moreno-Fierros
    • Fabio Salamanca-Gómez
    • Diego Arenas-Aranda
  • View Affiliations

  • Published online on: October 4, 2013     https://doi.org/10.3892/ijo.2013.2127
  • Pages: 1777-1786
  • Copyright: © Viedma-Rodriguez et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Apoptosis is controlled by the BCL-2 family of proteins, which can be divided into three different subclasses based on the conservation of BCL-2 homology domains. BIK is a founding member of the BH3-only pro-apoptotic protein family. BIK is predominantly localized in the endoplasmic reticulum (ER) and induces apoptosis through the mitochondrial pathway by mobilizing calcium from the ER to the mitochondria. In this study, we determined that suppression of the death gene Bik promotes resistance to tamoxifen (TAM) in MCF-7 breast cancer cells. We utilized small interfering (siRNA) to specifically knockdown BIK in MCF-7 cells and studied their response to tamoxifen. The levels of cell apoptosis, the potential mitochondrial membrane (∆Ψm), and the activation of total caspases were analyzed. Western blot analysis was used to determine the expression of some BCL-2 family proteins. Flow cytometry studies revealed an increase in apoptosis level in MCF-7 cells and a 2-fold increase in relative BIK messenger RNA (mRNA) expression at a concentration of 6.0 μM of TAM. BIK silencing, with a specific RNAi, blocked TAM-induced apoptosis in 45±6.78% of cells. Moreover, it decreased mitochondrial membrane potential (Ψm) and total caspase activity, and exhibited low expression of pro-apoptotic proteins BAX, BAK, PUMA and a high expression of BCl-2 and MCL-1. The above suggests resistance to TAM, regulating the intrinsic pathway and indicate that BIK comprises an important factor in the process of apoptosis, which may exert an influence the ER pathway, which regulates mitochondrial integrity. Collectively, our results show that BIK is a central component of the programmed cell death of TAM-induced MCF-7 breast cancer cells. The silencing of BIK gene will be useful for future studies to establish the mechanisms of regulation of resistance to TAM.
View Figures
View References

Related Articles

Journal Cover

December 2013
Volume 43 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Viedma-Rodriguez, R., Baiza-Gutman, L.A., García-Carrancá, A., Moreno-Fierros, L., Salamanca-Gómez, F., & Arenas-Aranda, D. (2013). Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells. International Journal of Oncology, 43, 1777-1786. https://doi.org/10.3892/ijo.2013.2127
MLA
Viedma-Rodriguez, R., Baiza-Gutman, L. A., García-Carrancá, A., Moreno-Fierros, L., Salamanca-Gómez, F., Arenas-Aranda, D."Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells". International Journal of Oncology 43.6 (2013): 1777-1786.
Chicago
Viedma-Rodriguez, R., Baiza-Gutman, L. A., García-Carrancá, A., Moreno-Fierros, L., Salamanca-Gómez, F., Arenas-Aranda, D."Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells". International Journal of Oncology 43, no. 6 (2013): 1777-1786. https://doi.org/10.3892/ijo.2013.2127